A Study on Diagnosis and Treatment of End Stage Liver Disease Complicated With Infection (SESLDIR Study)
NCT03363451
·
clinicaltrials.gov ↗
UNKNOWN
Status
2000
Enrollment
OTHER
Sponsor class
Conditions
End Stage Liver Disease
Infection
Interventions
DRUG:
Antibiotics
Sponsor
Tongji Hospital